Sitopaladi Churna in classical Ayurveda

What it is

Sitopaladi Churna is a classical polyherbal powder (churna) cited in authoritative texts including the Bhaishajya Ratnavali and the Charaka Samhita (neonatal surgery review). It contains five ingredients:

| Ingredient | Part | Classical proportion | |---|---|---| | Sitopala (sugar candy) | Saccharum officinarum | 16 parts | | Vamshalochana (bamboo manna) | Bambusa arundinacea, inner concretion | 8 parts | | Pippali (long pepper) | Piper longum fruit | 4 parts | | Ela (cardamom) | Elettaria cardamomum fruit | 2 parts | | Twak (cinnamon) | Cinnamomum zeylanicum bark | 1 part |

(composition per AFI-style tables; IRJAY 2023)

Note the sugar: half the powder is sugar candy. That shapes everything about its safety profile and its limits.

Classical properties

• Taste (rasa): sweet (Madhura)
• Qualities (guna): light (Laghu)
• Potency (virya): cooling (Sheeta)
• After digestion (vipaka): sweet (Madhura)
• Doshas: traditionally said to settle Pitta and Kapha; may increase Vata

Traditional use

Ayurveda describes Sitopaladi Churna as sweet (Madhura rasa), light (Laghu guna), cooling-to-neutral, pacifying Vata and Pitta. The classical indications are cough (kasa), dyspnoea, fever, rhinitis, and respiratory congestion. Modern summaries add cold, sore throat, bronchitis, pharyngeal and chest congestion, and allergic sneezing (neonatal surgery review).

The rationale is readable in the ingredients. Sugar candy soothes irritated throats. Long pepper is the heating bioenhancer and respiratory drug of the classical system. Cardamom and cinnamon are carminative aromatics. Bamboo manna is the mineral-silica component. Each ingredient's pharmacology contributes rather than one "active."

The old texts' claims end at this paragraph. Everything after it answers to modern evidence.

What research has looked at

Comparative clinical study (human)

Hajare (2023) ran a comparative clinical study of Sitopaladi Churna versus Vishwadi Churna in 40 patients with Vataja Kasa (dry cough with elevated eosinophil count). Twenty per group, treated for 30 days, then 15 days of follow-up. The study measured subjective parameters (dry cough, headache, chest pain, hoarseness, dry throat/mouth) and objective measures (eosinophil count, ESR, hemoglobin). Statistical analysis found Sitopaladi significantly more effective than Vishwadi on the tested parameters (IRJAY 2023).

Read it straight: 40 completers, convenience sampling, no blinding, no placebo, one center, one cough type. It is evidence, but weak evidence: the kind that supports further study, not clinical guidelines.

Laboratory work

Aqueous and methanol extracts of the churna were screened for antioxidant activity by DPPH and ABTS assays. Standard phytochemical characterization covered alkaloids, glycosides, flavonoids, tannins, sterols, and terpenes (Free Rad Antiox). Expect antioxidant results from a powder containing long pepper, cinnamon, and cardamom. This tells us about chemistry, not cough.

What the evidence does not support (yet)

No placebo-controlled trial of Sitopaladi Churna exists. The neonatal-surgery review's claim that "clinical studies have validated its effectiveness" overstates the record (review). One small unblinded comparison is not validation. No trial covers asthma, pneumonia, or bronchitis.

Safety notes

Generally safe as used traditionally. The ingredients are food-grade. The formulation is given to children and the elderly in classical practice. No toxicity signal was reported in the 40-patient study.

Cautions:

• Sugar content is ~50%. Diabetics should count it, and this is not a trivial fraction.
• Long pepper is pharmacologically active (piperine is a known CYP and P-gp modulator). Theoretical interactions with prescription drugs exist, unstudied for this formula.
• Cinnamon contains coumarin. Normal culinary use is fine, but medicinal-dose exposure adds up.
• It does not replace treatment for pneumonia, asthma exacerbations, tuberculosis, or any respiratory emergency. A cough persisting beyond a few weeks, or with blood, fever, or weight loss, needs a doctor, not a powder.
• The 30-day study excluded pregnant/lactating women and metabolic disease. No safety data for those groups.

FAQs

What is Sitopaladi Churna made of?

Five ingredients: sugar candy (16 parts), bamboo manna (8 parts), long pepper fruit (4 parts), cardamom (2 parts), and cinnamon bark (1 part) (IRJAY 2023).

Does it work for cough?

One comparative clinical study (n=40, unblinded) found it more effective than Vishwadi Churna for Vataja (dry, eosinophilic) cough over 30 days (IRJAY 2023). That is the entire clinical record, promising, not conclusive.

Is it safe for children?

Classical practice uses it across ages, and its ingredients are food-grade. The one clinical study was adults-only. Use pediatric products from reputable manufacturers and involve a clinician for infants.

Can diabetics take it?

It is roughly half sugar candy. Count it as sugar, consult your doctor, and do not let a sweet cough powder destabilize glucose control.

What is the classical dose?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Why is there no standard dosage section in this article?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Sources

The ingredient list and the 40-patient comparative trial (Vataja Kasa; 30 days; Sitopaladi statistically superior to Vishwadi on subjective and objective parameters) are Hajare, Int Res J Ayurveda Yoga 6(10), 2023 (PDF). The antioxidant and phytochemical screening (DPPH/ABTS) is Free Radicals and Antioxidants (abstract). The classical-text citations (Bhaishajya Ratnavali, Charaka Samhita) and respiratory indications are the 2025 critical review in J Neonatal Surg (PDF).

Disclaimer

This article is for educational purposes only and is not medical advice. Sitopaladi Churna is a traditional cough remedy with limited clinical evidence; it does not replace evaluation or treatment for pneumonia, asthma, tuberculosis, or persistent cough. Diabetics should account for its sugar content. Talk to a qualified healthcare practitioner before use, especially if pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.